170 related articles for article (PubMed ID: 11074471)
1. Increased immunoglobulin G, but not M, binding to endogenous retroviral antigens in HIV-1 infected persons.
Lawoko A; Johansson B; Rabinayaran D; Pipkorn R; Blomberg J
J Med Virol; 2000 Dec; 62(4):435-44. PubMed ID: 11074471
[TBL] [Abstract][Full Text] [Related]
2. Presence of antibodies to a putatively immunosuppressive part of human immunodeficiency virus (HIV) envelope glycoprotein gp41 is strongly associated with health among HIV-positive subjects.
Klasse PJ; Pipkorn R; Blomberg J
Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5225-9. PubMed ID: 2455899
[TBL] [Abstract][Full Text] [Related]
3. Characterization of antigens expressed in normal baboon trophoblast and cross-reactive with HIV/SIV antibodies.
Langat DK; Johnson PM; Rote NS; Wango EO; Owiti GO; Isahakia MA; Mwenda JM
J Reprod Immunol; 1999 Jan; 42(1):41-58. PubMed ID: 10098831
[TBL] [Abstract][Full Text] [Related]
4. T cell responses to human endogenous retroviruses in HIV-1 infection.
Garrison KE; Jones RB; Meiklejohn DA; Anwar N; Ndhlovu LC; Chapman JM; Erickson AL; Agrawal A; Spotts G; Hecht FM; Rakoff-Nahoum S; Lenz J; Ostrowski MA; Nixon DF
PLoS Pathog; 2007 Nov; 3(11):e165. PubMed ID: 17997601
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the specificities of IgG, IgG-subclass, IgA and IgM reactivities in African and European HIV-infected individuals with an HIV-1 clade C proteome-based array.
Gallerano D; Ndlovu P; Makupe I; Focke-Tejkl M; Fauland K; Wollmann E; Puchhammer-Stöckl E; Keller W; Sibanda E; Valenta R
PLoS One; 2015; 10(2):e0117204. PubMed ID: 25658330
[TBL] [Abstract][Full Text] [Related]
6. HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates.
Jones RB; Garrison KE; Mujib S; Mihajlovic V; Aidarus N; Hunter DV; Martin E; John VM; Zhan W; Faruk NF; Gyenes G; Sheppard NC; Priumboom-Brees IM; Goodwin DA; Chen L; Rieger M; Muscat-King S; Loudon PT; Stanley C; Holditch SJ; Wong JC; Clayton K; Duan E; Song H; Xu Y; SenGupta D; Tandon R; Sacha JB; Brockman MA; Benko E; Kovacs C; Nixon DF; Ostrowski MA
J Clin Invest; 2012 Dec; 122(12):4473-89. PubMed ID: 23143309
[TBL] [Abstract][Full Text] [Related]
7. Antibody to human endogenous retrovirus peptide in urine of human immunodeficiency virus type 1-positive patients.
Stevens RW; Baltch AL; Smith RP; McCreedy BJ; Michelsen PB; Bopp LH; Urnovitz HB
Clin Diagn Lab Immunol; 1999 Nov; 6(6):783-6. PubMed ID: 10548563
[TBL] [Abstract][Full Text] [Related]
8. IgA immunity in HIV type 1-infected chimpanzees. I. Systemic immunity.
Black KP; Fultz PN; Girard M; Jackson S
AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1263-72. PubMed ID: 9339843
[TBL] [Abstract][Full Text] [Related]
9. Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers.
de Mulder M; SenGupta D; Deeks SG; Martin JN; Pilcher CD; Hecht FM; Sacha JB; Nixon DF; Michaud HA
Retrovirology; 2017 Aug; 14(1):41. PubMed ID: 28830571
[TBL] [Abstract][Full Text] [Related]
10. Antibodies in human sera recognizing a recombinant outer membrane protein encoded by the envelope gene of the human endogenous retrovirus K.
Vogetseder W; Dumfahrt A; Mayersbach P; Schönitzer D; Dierich MP
AIDS Res Hum Retroviruses; 1993 Jul; 9(7):687-94. PubMed ID: 8396402
[TBL] [Abstract][Full Text] [Related]
11. A notable phenomenon recapitulated. A fusion product of a murine lymphoma cell and a leukemia virus-neutralizing antibody-producer host plasma cell formed spontaneously and secreting the specific antibody continuously.
Sinkovics JG
Acta Microbiol Immunol Hung; 2005; 52(1):1-40. PubMed ID: 15957233
[TBL] [Abstract][Full Text] [Related]
12. Detection of antibodies to a recombinant gag protein derived from human endogenous retrovirus clone 4-1 in autoimmune diseases.
Hishikawa T; Ogasawara H; Kaneko H; Shirasawa T; Matsuura Y; Sekigawa I; Takasaki Y; Hashimoto H; Hirose S; Handa S; Nagasawa R; Maruyama N
Viral Immunol; 1997; 10(3):137-47. PubMed ID: 9344336
[TBL] [Abstract][Full Text] [Related]
13. HIV infection and HERV expression: a review.
van der Kuyl AC
Retrovirology; 2012 Jan; 9():6. PubMed ID: 22248111
[TBL] [Abstract][Full Text] [Related]
14. Human endogenous retroviruses and cancer prevention: evidence and prospects.
Cegolon L; Salata C; Weiderpass E; Vineis P; Palù G; Mastrangelo G
BMC Cancer; 2013 Jan; 13():4. PubMed ID: 23282240
[TBL] [Abstract][Full Text] [Related]
15. Selective antibody reactivity with peptides from human endogenous retroviruses and nonviral poly(amino acids) in patients with systemic lupus erythematosus.
Bengtsson A; Blomberg J; Nived O; Pipkorn R; Toth L; Sturfelt G
Arthritis Rheum; 1996 Oct; 39(10):1654-63. PubMed ID: 8843855
[TBL] [Abstract][Full Text] [Related]
16. Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia.
Tomaras GD; Yates NL; Liu P; Qin L; Fouda GG; Chavez LL; Decamp AC; Parks RJ; Ashley VC; Lucas JT; Cohen M; Eron J; Hicks CB; Liao HX; Self SG; Landucci G; Forthal DN; Weinhold KJ; Keele BF; Hahn BH; Greenberg ML; Morris L; Karim SS; Blattner WA; Montefiori DC; Shaw GM; Perelson AS; Haynes BF
J Virol; 2008 Dec; 82(24):12449-63. PubMed ID: 18842730
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical localization of retroviral-related antigens expressed in normal baboon placental villous tissue.
Langat DK; Johnson PM; Rote NS; Wango EO; Owiti GO; Mwenda JM
J Med Primatol; 1998 Dec; 27(6):278-86. PubMed ID: 10203007
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus gp120 glycoprotein detected by a monoclonal antibody to a synthetic peptide.
Chanh TC; Kennedy RC; Alderete BE; Kanda P; Eichberg JW; Dreesman GR
Eur J Immunol; 1986 Nov; 16(11):1465-8. PubMed ID: 3023102
[TBL] [Abstract][Full Text] [Related]
19. Proteins antigenically related to peptides encoded by the mouse mammary tumour virus long terminal repeat sequence are associated with intracytoplasmic A particles.
Smith GH; Young LJ; Benjamini F; Medina D; Cardiff RD
J Gen Virol; 1987 Feb; 68 ( Pt 2)():473-86. PubMed ID: 3029286
[TBL] [Abstract][Full Text] [Related]
20. Anti-P30-52 monoclonal antibody cross-reacted to Env V3 and inhibited the viral multiplication of HIV-1-infected MT-4 cells.
Ota A; Bautista AN; Yadav ML; Ueda S
Hybridoma; 1999 Apr; 18(2):139-47. PubMed ID: 10380013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
